67 related articles for article (PubMed ID: 2806437)
1. High-dose methylprednisolone for acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S
Exp Hematol; 1989 Nov; 17(10):1051-2. PubMed ID: 2806437
[No Abstract] [Full Text] [Related]
2. Direct morphological evidence of high-dose methylprednisolone-induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S; Tuncer AM; Ertürk G; Ozbek N; Karadeniz N
Exp Hematol; 1991 Mar; 19(3):232-3. PubMed ID: 1995314
[No Abstract] [Full Text] [Related]
3. High-dose intravenous methylprednisolone in the treatment of acute nonlymphoblastic leukemia with ocular involvement.
Hiçsönmez G; Ozsoylu S; Tuncer M; Erer B
Turk J Pediatr; 1988; 30(3):181-3. PubMed ID: 3242191
[No Abstract] [Full Text] [Related]
4. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor.
Hiçsönmez G; Cetin M; Aslan D; Ozyürek E
Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535
[TBL] [Abstract][Full Text] [Related]
5. High-dose methylprednisolone in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S
Am J Hematol; 1990 Dec; 35(4):288-9. PubMed ID: 2239928
[No Abstract] [Full Text] [Related]
6. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.
Hiçsönmez G
Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential.
Hicsonmez G; Ozsoylu S; Tuncer AM
Leuk Res; 1991; 15(7):537-41. PubMed ID: 1861537
[No Abstract] [Full Text] [Related]
8. High-dose methylprednisolone for remission induction in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S; Gürgey A; Zamani VP; Irken G
Eur J Haematol; 1989 May; 42(5):498-500. PubMed ID: 2731596
[TBL] [Abstract][Full Text] [Related]
9. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia.
Elmas SA; Cetin M; Tuncer M; Hiçsönmez G
Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia.
Yildiran A; Erduran E; Tekelioğlu Y; Dilber E; Gedik Y
Turk J Pediatr; 2002; 44(2):116-21. PubMed ID: 12026198
[TBL] [Abstract][Full Text] [Related]
11. The potential role of high-dose methylprednisolone on the maturation of leukemic cells in children with acute promyelocytic leukemia (APL).
Hiçsönmez G; Tuncer AM; Güler E; Tan E; Tekelioglu M
Exp Hematol; 1993 May; 21(5):599-601. PubMed ID: 8513858
[No Abstract] [Full Text] [Related]
12. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
[TBL] [Abstract][Full Text] [Related]
13. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy.
Tunç B; Oner AF; Hiçsönmez G
Turk J Pediatr; 2002; 44(1):1-4. PubMed ID: 11858371
[TBL] [Abstract][Full Text] [Related]
14. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
15. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
[No Abstract] [Full Text] [Related]
16. The effect of high-dose methylprednisolone on CD34-positive bone marrow cells in the children with acute myeloblastic leukemia.
Tuncer AM; Hiçsönmez G; Gümrük F; Albayrak D; Duru F; Güzel E; Sayli T
Turk J Pediatr; 1995; 37(4):345-9. PubMed ID: 8560602
[TBL] [Abstract][Full Text] [Related]
17. Successful use of short-course high-dose methylprednisolone in a child with acute myeloblastic leukemia (FAB M2) and myeloid tumor.
Ozyurek E; Alioglu B; Coskun M; Ozbek N
Leuk Lymphoma; 2006 May; 47(5):923-5. PubMed ID: 16753881
[No Abstract] [Full Text] [Related]
18. [A case of acute leukosis and pregnancy. Antimitotic treatment and interruption of pregnancy by subtotal hysterectomy].
Pigeaud H; Reboul J; Eyraud A
Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(5):480-1. PubMed ID: 5234129
[No Abstract] [Full Text] [Related]
19. Comparision of the apoptotic effects on lymphoblasts and on increase of myeloid lineage cells of a short-time, high-dose methylprednisolone and the conventional-dose prednisolone treatments in children with acute lymphoblastic leukemia.
Erduran E; Tekelioglu Y; Karakas T; Gedik Y; Mert FM
Pediatr Hematol Oncol; 2006; 23(7):587-98. PubMed ID: 16928654
[TBL] [Abstract][Full Text] [Related]
20. Cell kinetics and chemotherapy in acute leukemia.
Lampkin BC; McWilliams NB; Mauer AM
Semin Hematol; 1972 Apr; 9(2):211-23. PubMed ID: 4502317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
